Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Chan-Jeoung Park
Increased Circulating Plasma Cells Detected by Flow Cytometry Predicts Poor Prognosis in Patients With Plasma Cell Myeloma
Cytometry Part B - Clinical Cytometry
Forensic Medicine
Pathology
Histology
Cell Biology
Prognostic Impact of Lymphocyte Subpopulations in Peripheral Blood After Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
Cytometry Part B - Clinical Cytometry
Forensic Medicine
Pathology
Histology
Cell Biology
Related publications
Increased Plasma Prothrombin Time Is Associated With Poor Prognosis in Patients With Paraquat Poisoning
Journal of Clinical Laboratory Analysis
Allergy
Immunology
Biochemistry
Public Health
Medical Laboratory Technology
Clinical Biochemistry
Hematology
Microbiology
Environmental
Occupational Health
Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis
PLoS ONE
Multidisciplinary
Prognosis Value of RBBP8 Expression in Plasma Cell Myeloma
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
Should We Be Routinely Testing for Circulating Clonal Plasma Cells in Patients With Multiple Myeloma?
Cytometry Part B - Clinical Cytometry
Forensic Medicine
Pathology
Histology
Cell Biology
Plasma Cell Satellitism in Plasma Cell Myeloma
Journal of Clinical Pathology
Medicine
Forensic Medicine
Pathology
Downregulation of Circulating Exosomal miR-638 Predicts Poor Prognosis in Colon Cancer Patients
Oncotarget
Oncology
Determination of Circulating Tumor Cells by Flow Cytometry in the Bladder Cancer Patients
Urology and Andrology – Open Journal
Increased Programmed Death Ligand-1 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma Patients
OncoTargets and Therapy
Oncology
Pharmacology
Post-Treatment Plasma EBV-DNA Positivity Predicts Early Relapse and Poor Prognosis for Patients With Extranodal NK/T Cell Lymphoma in the Era of Asparaginase
Oncotarget
Oncology
